CEREVEL THERAPEUTICS HLDNG I

CUSIP: 15678U128 Class: Common Stock

BAIN CAPITAL INVESTORS LLC's Holding History (CIK: 0001040508)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 65,679,781 Value ($000) $2,685,646 Avg Close Range
Q1 2024
Shares 65,679,781 Value ($000) $2,776,284 Avg Close Range
Q4 2023
Shares 65,679,781 Value ($000) $2,784,823 Avg Close Range
Q3 2023
Shares 60,199,729 Value ($000) $1,314,160 Avg Close Range
Q2 2023
Shares 60,199,729 Value ($000) $1,913,749 Avg Close Range
Q1 2023
Shares 60,632,356 Value ($000) $1,479 Avg Close Range
Q4 2022
Shares 60,632,356 Value ($000) $1,912 Avg Close Range
Q3 2022
Shares 60,632,356 Value ($000) $1,713,470 Avg Close Range
Q2 2022
Shares 60,632,356 Value ($000) $1,603,119 Avg Close Range
Q1 2022
Shares 60,632,356 Value ($000) $2,122,739 Avg Close Range
Q4 2021
Shares 60,632,356 Value ($000) $1,965,701 Avg Close Range
Q3 2021
Shares 60,632,356 Value ($000) $1,788,655 Avg Close Range
Q2 2021
Shares 60,632,356 Value ($000) $1,553,401 Avg Close Range
Q1 2021
Shares 60,632,356 Value ($000) $832,482 Avg Close Range
Q4 2020
Shares 60,632,356 Value ($000) $1,005,284 Avg Close Range